SEMKO; Christopher

Patent Applications and Registrations

Patent applications and USPTO patent grants for SEMKO; Christopher.The latest application filed is for "ras inhibitors".

Company Profile

6.20.28

SEMKO; Christopher - Fremont CA
SEMKO; Christopher - Redwood City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ras Inhibitors App 20210130326 - AGGEN; James ; et al.	2021-05-06
2,5-disubstituted 3-methyl Pyrazines And 2,5,6-trisubstituted 3-methyl Pyrazines As Allosteric Shp2 Inhibitors App 20210101870 - KOLTUN; Elena S. ; et al.	2021-04-08
Rapamycin Analogs As Mtor Inhibitors App 20210094975 - AGGEN; James Bradley ; et al.	2021-04-01
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors Grant 10,590,090 - Koltun , et al.	2020-03-17
Pyridine Compounds As Allosteric Shp2 Inhibitors App 20200017517 - GILL; Adrian ; et al.	2020-01-16
Bicyclic Compounds As Allosteric Shp2 Inhibitors App 20200017511 - BLANK; Brian R. ; et al.	2020-01-16
2,5-disubstituted 3-methyl Pyrazines And 2,5,6-trisubstituted 3-methyl Pyrazines As Allosteric Shp2 Inhibitors App 20190210977 - JOGALEKAR; Ashutosh ; et al.	2019-07-11
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,973,044 - Konradi , et al. July 5, 2	2011-07-05
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,968,547 - Konradi , et al. June 28, 2	2011-06-28
Heteroaryl, Heterocyclic And Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated By Vla-4 App 20100160341 - Konradi; Andrei W. ; et al.	2010-06-24
Heteroaryl, Heterocyclic And Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated By Vla-4 App 20100160343 - Konradi; Andrei W. ; et al.	2010-06-24
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,741,328 - Konradi , et al. June 22, 2	2010-06-22
Pyrimidinyl Sulfonamide Compounds Which Inhibit Leukocyte Adhesion Mediated By Vla-4 App 20100016345 - Smith; Jenifer ; et al.	2010-01-21
Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,579,466 - Smith , et al. August 25, 2	2009-08-25
Compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,538,215 - Konradi , et al. May 26, 2	2009-05-26
3-(heteroaryl)alanine Derivatives-inhibitors Of Leukocyte Adhesion Mediated By Vla-4 App 20080182850 - Konradi; Andrei W. ; et al.	2008-07-31
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,378,529 - Konradi , et al. May 27, 2	2008-05-27
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 Grant 7,365,073 - Konradi , et al. April 29, 2	2008-04-29
Pyrimidinyl Sulfonamide Compounds Which Inhibit Leukocyte Adhesion Mediated By Vla-4 App 20080058357 - Smith; Jenifer ; et al.	2008-03-06
Phenylalanine derivatives as alpha 4 integrin inhibitors Grant 7,291,645 - Konradi , et al. November 6, 2	2007-11-06
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20070099921 - Konradi; Andrei W. ; et al.	2007-05-03
Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,205,310 - Konradi , et al. April 17, 2	2007-04-17
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. Grant 7,049,306 - Konradi , et al. May 23, 2	2006-05-23
Heteroaryl-.beta.-alanine derivatives as alpha 4 integrin inhibitors Grant 7,015,216 - Konradi , et al. March 21, 2	2006-03-21
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,005,433 - Konradi , et al. February 28, 2	2006-02-28
Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4 App 20050261324 - Konradi, Andrei W. ; et al.	2005-11-24
Compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20050261293 - Konradi, Andrei W. ; et al.	2005-11-24
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 Grant 6,953,802 - Konradi , et al. October 11, 2	2005-10-11
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20050203093 - Konradi, Andrei W. ; et al.	2005-09-15
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 App 20050192280 - Konradi, Andrei W. ; et al.	2005-09-01
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,911,439 - Konradi , et al. June 28, 2	2005-06-28
Compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,903,088 - Konradi , et al. June 7, 2	2005-06-07
Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 App 20050085459 - Konradi, Andrei W. ; et al.	2005-04-21
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 App 20040266763 - Konradi, Andrei W. ; et al.	2004-12-30
Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 Grant 6,803,370 - Konradi , et al. October 12, 2	2004-10-12
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 Grant 6,794,506 - Konradi , et al. September 21, 2	2004-09-21
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20040147512 - Konradi, Andrei W. ; et al.	2004-07-29
Phenylalanine derivatives as alpha 4 integrin inhibitors App 20040127486 - Konradi, Andrei W. ; et al.	2004-07-01
Phenylalanine derivatives as alpha 4 integrin inhibitors Grant 6,689,781 - Konradi , et al. February 10, 2	2004-02-10
Compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030144328 - Konradi, Andrei W. ; et al.	2003-07-31
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated byVLA-4 App 20030139402 - Konradi, Andrei W. ; et al.	2003-07-24
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030125324 - Konradi, Andrei W. ; et al.	2003-07-03
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,492,372 - Konradi , et al. December 10, 2	2002-12-10
Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors App 20020086882 - Konradi, Andrei W. ; et al.	2002-07-04
Beta-amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 App 20020058664 - Konradi, Andrei W. ; et al.	2002-05-16
Phenylalanine derivatives as alpha 4 integrin inhibitors App 20020055509 - Konradi, Andrei W. ; et al.	2002-05-09
3-(Heteroaryal) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 App 20020052375 - Konradi, Andrei W. ; et al.	2002-05-02
Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 App 20020052470 - Konradi, Andrei W. ; et al.	2002-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.